Cancer Progress 2016

To ACCESS THIS SITE AGAIN, PLEASE COPY THIS LINK AS A FAVORITE

http://www2.cancerprogressbydh.com/cancer-progress-2016/

Tuesday, March 8, 2016
7:00 – 8:00am Registration and Continental Breakfast
8:00 – 8:15am Opening Remarks
Audio file: 
8:15 – 9:15am Keynote: Cancer Moonshot 2020 & The National Immunotherapy Coalition (NIC)
Patrick Soon-Shiong, MD, FRCS (C), FACS, Executive Chairman and Founder, NantHealth
Audio file:
9:15 – 10:30am Revisiting Melanoma: From Intractable to Curable
Moderator: Paul B. Chapman, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center
Audio file:
Panelists:

  • Laura Brockway-Lunardi, PhD, Scientific Program Director, Melanoma Research Alliance
  • Alexandre Avila, MD, PhD, Director, I-O Medical Lead, Melanoma, Bristol Myers Squibb
  • Jennifer Gansert, MD, PhD, Executive Medical Director, Oncology Therapeutics, Amgen
  • Jedd D. Wolchok, MD, PhD, Chief, Melanoma & Immunotherapeutics Service; Lloyd J. Old/Virginia and Daniel K. Ludwig Chair in Clinical Investigation, Memorial Sloan Kettering Cancer Center
10:30 – 11:00am Networking Break
11:00 – 12:15pm Myeloma: Opportunities & Challenges in Moving Toward a Cure
Moderator: Mike Rice, MS, MBA, Senior Consultant, Defined Health
Audio file:
Panelists:

12:15 – 1:30pm Networking Luncheon
1:30 – 2:45pm Investing in Oncology – A New Math or Same Old Same Old?
Moderator: Mark Simon, Partner, Torreya Partners
Audio file:
Panelists:

  • John DeYoung, VP, Worldwide Business Development, Pfizer Inc.
  • Richard Brian Gaynor, MD, Sr. Vice President Global Development & Medical Affairs, Oncology Business Unit, Eli Lilly and Company
  • Axel Hoos, MD, PhD, Senior Vice President, Oncology R&D, GlaxoSmithKline
  • David R. Parkinson, MD, Venture Partner, New Enterprise Associates, Inc.
  • Ferran Prat, PhD, JD, VP, Strategic Industry Ventures, The University of Texas MD Anderson Cancer Center
2:45 – 4:00pm From Novel Science to Clinical Development: Stories from Small Biotechs
Moderator: Jeremy P. Goldberg, Advisor, Torreya Partners
Audio file:
Panelists:

4:00 – 4:15pm Networking Break
4:15 – 5:30pm Parsing the Data, Vetting the Value
Moderator: Ed Saltzman, President, Defined Health
Audio file:
Panelists:

5:30 – 7:00pm Cancer Progress 2016 Reception
Wednesday, March 9, 2016
7:00 – 8:00am Continental Breakfast
8:00 – 8:15am Opening Remarks
Audio file:
8:15 – 9:15am Day 2 Keynote: The Game Theory of the Global Cancer Moonshot
  • Peter Kolchinsky, PhD, Managing Director, RA Capital Management, LLC
Audio file:
9:15 – 10:30am Immuno-Oncology I: Attacking Cancer Antigens – Exploiting off-the-Shelf and Personalized Vaccines and Triggering of Immunogenic Cell Death
Moderator: Jeffrey M. Bockman, PhD, Vice President, Defined Health
Audio file:
Panelists:

10:30 – 10:45am Networking Break
10:45 – 12:00pm Immuno-Oncology II: Next Wave IO Targets and Modalities
Moderator: Jeffrey M. Bockman, PhD, Vice President, Defined Health
Audio file:
Panelists:

12:00 – 1:15pm Networking Luncheon
1:15 – 2:30pm N-of-One Trials: Is This the Future of Oncology Drug Development?
Moderator: Brian Leyland-Jones, MB BS, PhD, Vice President of the Avera Center for Precision Oncology and the Department of Molecular and Experimental Medicine, Avera Cancer Institute, Consulting Professor, Stanford University School of Medicine
Audio file:
Panelists:

2:30 – 3:45pm Novel MOA: RNA as a Target and a Therapeutic
Moderator: Mike Rice, MS, MBA, Senior Consultant, Defined Health
Audio file:
Panelists:

3:45 Cancer Progress 2016 Conference Concludes
Day two wrap up!